Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Animals
1.2.3 Plants
1.2.4 Pathogens
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Gene Testing and Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Medical Industry
1.3.3 Agriculture
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Gene Testing and Diagnostics Market Perspective (2018-2033)
2.2 CRISPR Gene Testing and Diagnostics Growth Trends by Region
2.2.1 Global CRISPR Gene Testing and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR Gene Testing and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 CRISPR Gene Testing and Diagnostics Market Dynamics
2.3.1 CRISPR Gene Testing and Diagnostics Industry Trends
2.3.2 CRISPR Gene Testing and Diagnostics Market Drivers
2.3.3 CRISPR Gene Testing and Diagnostics Market Challenges
2.3.4 CRISPR Gene Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue
3.1.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue (2018-2023)
3.1.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR Gene Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Gene Testing and Diagnostics Revenue
3.4 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio
3.4.1 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Testing and Diagnostics Revenue in 2022
3.5 CRISPR Gene Testing and Diagnostics Key Players Head office and Area Served
3.6 Key Players CRISPR Gene Testing and Diagnostics Product Solution and Service
3.7 Date of Enter into CRISPR Gene Testing and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Gene Testing and Diagnostics Breakdown Data by Type
4.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2024-2033)
5 CRISPR Gene Testing and Diagnostics Breakdown Data by Application
5.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR Gene Testing and Diagnostics Market Size (2018-2033)
6.2 North America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023)
6.4 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Gene Testing and Diagnostics Market Size (2018-2033)
7.2 Europe CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023)
7.4 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Gene Testing and Diagnostics Market Size (2018-2033)
9.2 Latin America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023)
9.4 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Introduction
11.1.4 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.1.5 10x Genomics Recent Development
11.2 Aelian Biotechnology
11.2.1 Aelian Biotechnology Company Detail
11.2.2 Aelian Biotechnology Business Overview
11.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Introduction
11.2.4 Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.2.5 Aelian Biotechnology Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Introduction
11.3.4 Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Axxam
11.4.1 Axxam Company Detail
11.4.2 Axxam Business Overview
11.4.3 Axxam CRISPR Gene Testing and Diagnostics Introduction
11.4.4 Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.4.5 Axxam Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Introduction
11.5.4 Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Detail
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Introduction
11.6.4 Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Binx Health
11.7.1 Binx Health Company Detail
11.7.2 Binx Health Business Overview
11.7.3 Binx Health CRISPR Gene Testing and Diagnostics Introduction
11.7.4 Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.7.5 Binx Health Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Detail
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux CRISPR Gene Testing and Diagnostics Introduction
11.8.4 bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Introduction
11.9.4 Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Caspr Biotech
11.10.1 Caspr Biotech Company Detail
11.10.2 Caspr Biotech Business Overview
11.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Introduction
11.10.4 Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.10.5 Caspr Biotech Recent Development
11.11 ERS Genomics
11.11.1 ERS Genomics Company Detail
11.11.2 ERS Genomics Business Overview
11.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Introduction
11.11.4 ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.11.5 ERS Genomics Recent Development
11.12 FASMAC
11.12.1 FASMAC Company Detail
11.12.2 FASMAC Business Overview
11.12.3 FASMAC CRISPR Gene Testing and Diagnostics Introduction
11.12.4 FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.12.5 FASMAC Recent Development
11.13 Illumina
11.13.1 Illumina Company Detail
11.13.2 Illumina Business Overview
11.13.3 Illumina CRISPR Gene Testing and Diagnostics Introduction
11.13.4 Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.13.5 Illumina Recent Development
11.14 Janssen Diagnostics
11.14.1 Janssen Diagnostics Company Detail
11.14.2 Janssen Diagnostics Business Overview
11.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Introduction
11.14.4 Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.14.5 Janssen Diagnostics Recent Development
11.15 Locus Biosciences
11.15.1 Locus Biosciences Company Detail
11.15.2 Locus Biosciences Business Overview
11.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.15.4 Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.15.5 Locus Biosciences Recent Development
11.16 Mammoth Biosciences
11.16.1 Mammoth Biosciences Company Detail
11.16.2 Mammoth Biosciences Business Overview
11.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.16.4 Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.16.5 Mammoth Biosciences Recent Development
11.17 NRGene
11.17.1 NRGene Company Detail
11.17.2 NRGene Business Overview
11.17.3 NRGene CRISPR Gene Testing and Diagnostics Introduction
11.17.4 NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.17.5 NRGene Recent Development
11.18 Roche
11.18.1 Roche Company Detail
11.18.2 Roche Business Overview
11.18.3 Roche CRISPR Gene Testing and Diagnostics Introduction
11.18.4 Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.18.5 Roche Recent Development
11.19 Sherlock Biosciences
11.19.1 Sherlock Biosciences Company Detail
11.19.2 Sherlock Biosciences Business Overview
11.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.19.4 Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.19.5 Sherlock Biosciences Recent Development
11.20 Thermo Fisher Scientific
11.20.1 Thermo Fisher Scientific Company Detail
11.20.2 Thermo Fisher Scientific Business Overview
11.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Introduction
11.20.4 Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.20.5 Thermo Fisher Scientific Recent Development
11.21 Vivlion
11.21.1 Vivlion Company Detail
11.21.2 Vivlion Business Overview
11.21.3 Vivlion CRISPR Gene Testing and Diagnostics Introduction
11.21.4 Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023)
11.21.5 Vivlion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Animals
Table 3. Key Players of Plants
Table 4. Key Players of Pathogens
Table 5. Key Players of Others
Table 6. Global CRISPR Gene Testing and Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global CRISPR Gene Testing and Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global CRISPR Gene Testing and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2018-2023)
Table 10. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2024-2033)
Table 12. CRISPR Gene Testing and Diagnostics Market Trends
Table 13. CRISPR Gene Testing and Diagnostics Market Drivers
Table 14. CRISPR Gene Testing and Diagnostics Market Challenges
Table 15. CRISPR Gene Testing and Diagnostics Market Restraints
Table 16. Global CRISPR Gene Testing and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global CRISPR Gene Testing and Diagnostics Market Share by Players (2018-2023)
Table 18. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2022)
Table 19. Ranking of Global Top CRISPR Gene Testing and Diagnostics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by CRISPR Gene Testing and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CRISPR Gene Testing and Diagnostics Product Solution and Service
Table 23. Date of Enter into CRISPR Gene Testing and Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Gene Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2024-2033)
Table 29. Global CRISPR Gene Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2018-2023)
Table 31. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2024-2033)
Table 33. North America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 48. 10x Genomics Company Detail
Table 49. 10x Genomics Business Overview
Table 50. 10x Genomics CRISPR Gene Testing and Diagnostics Product
Table 51. 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 52. 10x Genomics Recent Development
Table 53. Aelian Biotechnology Company Detail
Table 54. Aelian Biotechnology Business Overview
Table 55. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product
Table 56. Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 57. Aelian Biotechnology Recent Development
Table 58. Agilent Technologies Company Detail
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies CRISPR Gene Testing and Diagnostics Product
Table 61. Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 62. Agilent Technologies Recent Development
Table 63. Axxam Company Detail
Table 64. Axxam Business Overview
Table 65. Axxam CRISPR Gene Testing and Diagnostics Product
Table 66. Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 67. Axxam Recent Development
Table 68. Beckman Coulter Company Detail
Table 69. Beckman Coulter Business Overview
Table 70. Beckman Coulter CRISPR Gene Testing and Diagnostics Product
Table 71. Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 72. Beckman Coulter Recent Development
Table 73. Becton, Dickinson and Company Company Detail
Table 74. Becton, Dickinson and Company Business Overview
Table 75. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product
Table 76. Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 77. Becton, Dickinson and Company Recent Development
Table 78. Binx Health Company Detail
Table 79. Binx Health Business Overview
Table 80. Binx Health CRISPR Gene Testing and Diagnostics Product
Table 81. Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 82. Binx Health Recent Development
Table 83. bioMérieux Company Detail
Table 84. bioMérieux Business Overview
Table 85. bioMérieux CRISPR Gene Testing and Diagnostics Product
Table 86. bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 87. bioMérieux Recent Development
Table 88. Bio-Rad Laboratories Company Detail
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product
Table 91. Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Caspr Biotech Company Detail
Table 94. Caspr Biotech Business Overview
Table 95. Caspr Biotech CRISPR Gene Testing and Diagnostics Product
Table 96. Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 97. Caspr Biotech Recent Development
Table 98. ERS Genomics Company Detail
Table 99. ERS Genomics Business Overview
Table 100. ERS Genomics CRISPR Gene Testing and Diagnostics Product
Table 101. ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 102. ERS Genomics Recent Development
Table 103. FASMAC Company Detail
Table 104. FASMAC Business Overview
Table 105. FASMAC CRISPR Gene Testing and Diagnostics Product
Table 106. FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 107. FASMAC Recent Development
Table 108. Illumina Company Detail
Table 109. Illumina Business Overview
Table 110. Illumina CRISPR Gene Testing and Diagnostics Product
Table 111. Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 112. Illumina Recent Development
Table 113. Janssen Diagnostics Company Detail
Table 114. Janssen Diagnostics Business Overview
Table 115. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product
Table 116. Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 117. Janssen Diagnostics Recent Development
Table 118. Locus Biosciences Company Detail
Table 119. Locus Biosciences Business Overview
Table 120. Locus Biosciences CRISPR Gene Testing and Diagnostics Product
Table 121. Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 122. Locus Biosciences Recent Development
Table 123. Mammoth Biosciences Company Detail
Table 124. Mammoth Biosciences Business Overview
Table 125. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product
Table 126. Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 127. Mammoth Biosciences Recent Development
Table 128. NRGene Company Detail
Table 129. NRGene Business Overview
Table 130. NRGene CRISPR Gene Testing and Diagnostics Product
Table 131. NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 132. NRGene Recent Development
Table 133. Roche Company Detail
Table 134. Roche Business Overview
Table 135. Roche CRISPR Gene Testing and Diagnostics Product
Table 136. Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 137. Roche Recent Development
Table 138. Sherlock Biosciences Company Detail
Table 139. Sherlock Biosciences Business Overview
Table 140. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product
Table 141. Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 142. Sherlock Biosciences Recent Development
Table 143. Thermo Fisher Scientific Company Detail
Table 144. Thermo Fisher Scientific Business Overview
Table 145. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product
Table 146. Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 147. Thermo Fisher Scientific Recent Development
Table 148. Vivlion Company Detail
Table 149. Vivlion Business Overview
Table 150. Vivlion CRISPR Gene Testing and Diagnostics Product
Table 151. Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 152. Vivlion Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Gene Testing and Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CRISPR Gene Testing and Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Animals Features
Figure 4. Plants Features
Figure 5. Pathogens Features
Figure 6. Others Features
Figure 7. Global CRISPR Gene Testing and Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global CRISPR Gene Testing and Diagnostics Market Share by Application: 2022 VS 2033
Figure 9. Medical Industry Case Studies
Figure 10. Agriculture Case Studies
Figure 11. Others Case Studies
Figure 12. CRISPR Gene Testing and Diagnostics Report Years Considered
Figure 13. Global CRISPR Gene Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global CRISPR Gene Testing and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global CRISPR Gene Testing and Diagnostics Market Share by Region: 2022 VS 2033
Figure 16. Global CRISPR Gene Testing and Diagnostics Market Share by Players in 2022
Figure 17. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CRISPR Gene Testing and Diagnostics Revenue in 2022
Figure 19. North America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America CRISPR Gene Testing and Diagnostics Market Share by Country (2018-2033)
Figure 21. United States CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe CRISPR Gene Testing and Diagnostics Market Share by Country (2018-2033)
Figure 25. Germany CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Share by Region (2018-2033)
Figure 33. China CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America CRISPR Gene Testing and Diagnostics Market Share by Country (2018-2033)
Figure 41. Mexico CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Share by Country (2018-2033)
Figure 45. Turkey CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. 10x Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 48. Aelian Biotechnology Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 49. Agilent Technologies Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 50. Axxam Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 51. Beckman Coulter Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 53. Binx Health Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 54. bioMérieux Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 56. Caspr Biotech Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 57. ERS Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 58. FASMAC Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 59. Illumina Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 60. Janssen Diagnostics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 61. Locus Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 62. Mammoth Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 63. NRGene Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 64. Roche Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 65. Sherlock Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 67. Vivlion Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed